Testing effectiveness (Phase 2)Study completedNCT05085561
What this trial is testing
The Symptomatic Cerebral Cavernous Malformation Trial of REC-994
Who this might be right for
Cerebral Cavernous Malformation
Recursion Pharmaceuticals Inc. 62
Showing 3 of 3 results